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Abstract--A synthetic investi :ation ofcopper(II) ibuprofenate (lbup) addition compounds with 2,2'-bipyridine 
(bpy), 1,10-phenanthroline (phen) and 2,9-dimethyl-l,10-phenanthroline (dmph) has led to the isolation of 
dinuclear adducts of the forms [Cu(Ibup)2(bpy)]z'4H20 (1) and [Cu(Ibup)2(phen)]2 ( ) and a mononuclear 
adduct Cu(lbup)2(dmph) (3). Spectroscopic data for adducts 1 and 2 are consistent with a dinuclear structure 
with two CuN202+O chromophors. Each copper is coordinated with two ibuprofenate bridges, a terminal 
diimine molecule and a monodentate ibuprofenate group complete five-coordination at each metal atom. 
Spectroscopic data for adduct 3 are consistent with a mononuclear structure having a very distorted square- 
pyramidal CuN202+O chromophore. The Cu H atom is coordinated to two nitrogen atoms from a chelating 
dmph ligand, two carboxylic oxygens of a bidentate ibuprofenate ion and an oxygen atom of a monodentate 
carboxylic group of a second ibuprofenate ion. The reduction of adduct (3) by ascorbic acid produced stable 
red copper(I) complex of the form [Cu(dmph)2] (Ibup) (4). Spectral data of this adduct indicated that the 
cation has distorted tetrahedral geometry about he copper atom. The effect of I and 2 on the rate of hydrolysis 
of bis(p-nitrophenyl) phosphate (BNPP) have been examined in aqueous methanol solution at 70'C and pH 
7.4. Copyright ~ 1996 Elsevier Science Ltd 
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It has been suggested that copper(ll) complexes of anti- 
inflammatory drugs are often more active and desir- 
able drugs than the parent ligands themselves [1]. Ibu- 
profen [2-(4-isobutylphenyl)propionic acid], [Scheme 
1] is a non-steroidal anti-inflammatory drug and 
has been used for many years in the treatment of 
inflammatory diseases. Physical studies of copper(lI) 
ibuprofenate [2] have shown that it contains dinuclear 
units with bridging carboxylates, imilar to the fam- 
iliar copper acetate and many other copper(II) car- 
boxylates [3]. It is well known that many copper(ll) 
carboxylates form dinuclear adducts with basic 
CHCH 2 C]-I 
~ /  \GO2H 
Scheme 1. 
ligands [3,4] ; however, with certain bases many cop- 
per(I1) carboxylates also form mononuclear adducts 
[3b,4-8]. Several studies from our laboratories and 
others have been designed to investigate the factors 
which influence the adoption of either dinuclear or 
mononuclear complexes for copper(ll) carboxylate 
adducts [3a,4~10]. In general, ithas been found that by 
increasing the acidity of the alkyl (or aryl) carboxylate 
ligands, such as through halogenation ofalkyl groups 
and/or by increasing the basicity of the other ligands, 
the tendency towards formation of mononuclear com- 
plexes increases [2b,4-- 10]. 
Our interest in copper(ll) carboxylate complexes 
with nitrogen-donor ligands evolves from their bio- 
logical implications [1,4,7,11]. As an example, the imi- 
dazole and carboxylate groups are the ligating 
moieties found in proteins and in many naturally 
occurring mixed-ligand complexes [12]. In addition, 
mononuclear and dinuclear copper(li) carboxylates 
and their nitrogen-donor adducts have been found 
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to have a variety of pharmacological effects, such as 
antitumour [1,13], superoxide dismutase [14], cat- 
echolase [4,7], cytotoxicity and antiviral activities [11]. 
Chelators such as 2,2'-bipyridine and 1,10-phen- 
anthroline have potential antitumour activity and 
their activity may be increased through their chelation 
to the copper ion [15]. A complex between the chel- 
ating agent 1,10-phenanthroline a d copper(II) is able 
to induce the degradation of DNA in the presence of 
reducing agents[16] and 2,2'-bipyridine complexes of 
copper(II) have been used as non-enzymatic catalysts 
for the hydrolytic leavage of phosphodiester back- 
bone of DNA and RNA [17,18]. There has been inter- 
est in developing metal complexes which can promote 
hydrolysis of phosphate sters as model systems for 
metallo-phosphatase enzymes and as catalysts for the 
detoxification of man-made phosphorus(V) toxins of 
some pesticides and chemical weapons [17,18]. In 
addition, the development of new artificial photo- 
synthetic assemblies capable of harvesting solar 
energy is of great interest in inorganic photochemistry 
[19]. Cuprous diimine chromophores have received 
considerable attention since these chromophores dis- 
play metal-to-ligand charge transfer (MLCT) bands 
in the visible region [20]. Recently, light excitation 
into these bands leads to room-temperature emission 
in argon dichloromethane solution and the photo- 
driven energy transfer from cuprous phenanthroline 
derivatives has been demonstrated [21]. As part of an 
ongoing investigation i to the biological and photo- 
chemical activities of copper compounds, this article 
reports the synthesis and spectroscopic harac- 
terization of ternary complexes of copper(II) ibu- 
profenate with 2,2'-bipyridine, 1,10-phenanthroline 
and 2,9-dimethyl-l,10-phenanthroline and xamines 
the activities of the first two complexes for the 
hydrolysis of bis(p-nitrophenyl)phosphate. In 
addition, the reduction of copper(II) ibuprofenate 
adduct of 2,9-dimethyl-l,10-phenanthroline to 
bis(2,9-dimethyl-l,10-phenanthroline) copper(I) ibu- 
profenate is also reported. 
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Preparation of complexes 
[Cu(Ibup)2(bpy)]2"4H20 (1). A solution of 2,2'- 
biypridine (0.164 g, 1.05 mmol) in methanol (50 cm 3) 
was added to Cu2 (Ibup)4 (0.496, 0.524 mmol). The 
mixture was stirred at room temperature for 2 h. The 
blue solution was filtered and left in the hood to evap- 
orate. The bluish-green precipitate that formed was 
recrystallized from chloroform and air dried. Yield 
0.58 g (83%). Found: C 65.0; H, 7.0; N, 4.1. Calc. 
for C72H92N4OI2Cu 2 : C, 64.9 ; H, 6.9 ; N, 4.2%. 
[Cu(Ibup)2(phen)]2 ( ). A solution of 1,10-phen- 
anthroline (0.133 g, 0.68 mmol) in methanol (50 cm 3) 
was added to Cuz(Ibup)z (0.319 g, 0.337 mmol). The 
mixture was stirred at room temperature for 2 h. The 
bluish-green solution was filtered and left in the hood 
to evaporate. The sky-blue precipitate that formed 
was recrystallized from chloroform and air dried. 
Yield 0.38 g (86%). Found: C 70.0; H, 6.6; N, 4.2. 
Calc. for C76H84N4OsCu2 : C, 69.8; H, 6.4; N, 4.3%. 
Cu(Ibup)z(dmph) (3). A solution of 2,9-dimethyl- 
1,10-phenanthroline (0.176 g, 0.845 mmol) in meth- 
anol (50 cm 3) was added to Cu2(Ibup)4 (0.398 g, 0.420 
mmol). The solution was protected from the light and 
stirred at room temperature for 3 h. The green solution 
was filtered and left in the hood to evaporate. The 
green precipitate that formed was recrystallized from 
chloroform and air dried. Yield 0.37 g (65%). Found : 
C, 70.1 ; H, 6.9 ; N, 4.0. Calc. for C40H46N204CH : C, 
70.4; H, 6.8; N, 4.1%. 
[Cu(dmph)2]Ibup (4). Solid ascorbic acid (0.053 g, 
0.30 mmol) was added to the green solution of 3 (0.2 
g, 0.29 mmol) in acetonitrile (15 cm3). The red solution 
which formed was stirred for 15 min, filtered and left 
in the hood to evaporate. The red oily product was 
dissolved in dichloromethane (20 cm 3) and filtered. 
The red filtrate was concentrated byslow evaporation 
to ca 2 cm 3 then anhydrous diethylether was added 
to the solution with stirring until the red precipitate 
formed. The complex was filtered under reduced pres- 
sure, washed several times with anhydrous diethyether 
and dried in vacuo. Yield 0.045 g (45%). Found: C, 
71.2; H, 6.1; N, 8.4. Calc. for C41HalN402Cu: C, 
71.9; H, 6.0; N, 8.2%. 
EXPERIMENTAL 
Materials 
2,2'-Bipyridine (bpy), 1,10-phenanthroline(phen) 
and 2,9-dimethyl-l,10-phenanthroline (dmph) were 
purchased from Aldrich ; sodium bis(p-nitro- 
phenyl)phosphate (BNPP) and biological buffer 
HEPES [N-(2-hydroxyethyl) piperazine-N'-ethane- 
sulfonic acid] were from Sigma and used without 
further purification. Tetrakis(/~-ibuprofenato) dicop- 
per(II), [Cuz(Ibup)4] (lbup = ibuprofenate ion), was 
prepared as described previously [2b] and recrys- 
tallized from anhydrous diethylether: dichloro- 
methane (1 : 1). 
Physical measurements 
Elemental analyses for C, H and N were performed 
by Galbraith Laboratories, Knoxville, Tennessee, 
U.S.A. Room-temperature (298 K) magnetic sus- 
ceptibility measurements of powdered and solution 
samples were determined as described previously [4,6]. 
Electronic data of dichloromethane solutions were 
obtained with a Bausch and Lomb Spectronic 2000. 
IR spectra of Nujol or hexachlorobutadiene mulls 
sealed between polyethylene sheets were obtained in 
the 4000-200 cm- J region with a Perkin-Elmer model 
843 IR spectrophotometer. X-band ESR spectra of 
polycrystalline material and of methanol/toluene solu- 
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tions were obtained at room temperature and 77 K 
with an ESPIT-330 Vol. 501 spectrometer. Diphenyl- 
picrylhydrazide (DPPH, g -= 2.0036) was used as the 
calibrating field marker. A Varian 360A-60MHz spec- 
trometer was used to obtain NMR spectra nd chemi- 
cal shifts were referenced to SiMe4. 
Kinetics 
All kinetic studies were performed at 70°C and pH 
7.4 with temperature compensation probe. The Sigma 
biological buffer HEPES (5 mmol dm -3) was used to 
maintain a constant pH at 7.4. The pH of the buffer 
solutions was adjusted with NaOH or HNO3 and 
checked at 70°C. Kinetic measurements were per- 
formed with the use of Bausch and Lomb 2000 UV- 
vis spectrophotometer equipped with a thermostated 
cell compartment. 
The hydrolysis of sodium bis(p-nitrophenyl) phos- 
phate (BNPP) by copper(II) complexes was moni- 
tored spectrophotometrically b following the 
production ofp-nitrophenolate  400 nm (~ = 14 000 
M ~ cm ~, pH = 7.4) [17a]. The reactions were car- 
ried out under pseudo-first-order conditions with an 
excess copper(lI) complex over BNPP concentrations. 
In a typical kinetic experiment, 1.5 cm 3 (2 x 10 3 M) 
of copper(II) complex dissolved in methanol and 1.5 
cm 3 (1 x 10 -4 M) of BNPP dissolved in HEPES buffer 
(pH 7.4) were combined in a 1 cm quartz cell and the 
absorbance hanges at 400 nm were recorded at 70°C 
against he reference cell under identical conditions, 
except copper(II) complex was omitted. The final con- 
centrations in the cell were (1 x 10 3 M) copper(II) 
complex and (5 x 10 -5 M) BNPP. 
First-order ate constants, kob s (S-l), were cal- 
culated from the slope of the linear plots of absorb- 
ance against time by converting toconcentration u its 
and dividing by the initial BNPP concentration. All 
experiments were run in triplicate and the first-order 
rate constants represent the average of these exper- 
iments. 
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Magnetic and spectroscopic haracterization 
The ESR parameters, g and A, for frozen solutions 
and solid-state spectra of complexes studied are given 
in Table 1. The room-temperature ESR spectra of 
solid state samples of 1, 2 and 3 are anisotropic and 
contain g~ and gx components. Two of the four cop- 
per(II) hyperfine components in the g~ region for com- 
plex 3 are partially resolved. These spectra re of axial 
type (q~ > g± > 2.040), suggesting tbr all compounds 
dx:-,'- (or d,,.) ground state, characteristic of a square- 
planar, square-based pyramidal or octahedral stereo- 
chemistry [22]. 
Frozen-solution ESR spectra of complexes 1 and 2 
in 3.0 kG region exhibit a resolved structure with 
g,~ > gi (Table 1) and a representative frozen solution 
spectrum is that of 1 shown in Fig. 1. In addition to 
the hyperfine structure of copper(l l) in the g, region, 
the 91 regions of these spectra exhibit ~4N-super-hyp- 
erfine structure consisting of five lines. This structure 
is attributed to the presence of two nitrogen atoms in 
the plane of the copper(ll) ion. The spectral par- 
ameters for the complexes are comparable to those 
previously reported complexes that have square-based 
CuN202 of tetragonally elongated CuN:O2 +-O or 
CuN20: + Oz chromophore, including those reported 
for copper(II) carboxylates with a,~ -diimine [4 7, 
23]. In these complexes the copper(It) ion is bonded 
to two unidentate nitrogen donors (e.g. imidazoles) 
or one bidentate chelate a,~ -diimine ligand and one 
oxygen atom from each of the two carboxylate anions. 
The second oxygen atom of each carboxylate ligand 
is in a weakly pseudo-axial position [5.7,9,11,24]. 
In addition to the above signals expected for 
AMs = 1 allowed transition of magnetic dilute cop- 
I per(II) complexes S=5, the ESR spectra lbr com- 
plexes 1 and 2 in the full ESR region show another 
three weak signals at about 1200, 2230 and 3830 G 
and a representative spectrum is that of 2 shown in 
Fig. 2(a). These signals are attributed to the spin- 
Table 1. ESR data for copper(lI) ibuprofenates 
State 
Compound (temperature) ~ Y l 91 
AiiCu 
(× 104 cm ') 
A,N 
{ × 10acre ~) 
1 Solid (room) 2.128 2.255 2.064 
Frozen (77 K) 2.134 2.277 2.063 
2 Solid (room) 2.122 2.243 2.061 
Frozen (77 K) 2.141 2.286 2.069 
3 Solid (room) 2.172 2.362 2.082 
Frozen (77 K) 2.169 2.337 9x = 2.035 
g~ = 2.134 
221 
222 
167 
14 
14 
I "go values are calculated from the equation g0 = ~ (.q, +29±). 
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Fig. 1. Frozen-solution ESR spectrum of compound 1. 
triplet state with S = 1. The signals at 2230 and 3830 
G are devoid of any hyperfine structure, they are 
assigned to the AM,. = 1 transitions Hxy~ and Hxy2 
[24@ The weak signal at 1200 G showed a resolved 
seven-line hyperfine structure (A = 100 × 10 4 cm-1) 
and is attributed to the half-field AM, = 2 forbidden 
transition in dinuclear copper(II) complexes [25]. The 
positions and the assignment of these signals are com- 
parable with those found for dicopper(II) complexes 
having an acetate ion-bridged ligand [25] and with 
those reported recently for ternary dinuclear cop- 
per(II) complexes of 4-aminobenzoic acid with 4,7- 
disubstituted phenanthrolines [26]. In these com- 
plexes each copper atom is coordinated with two 4- 
aminobenzoate bridges, a terminal diimine molecule 
and the fifth coordination position is occupied by a 
water molecule. In addition, the hyperfine coupling 
constant observed, 100 x 10 -4  cm - l ,  is about one half 
of that of mononuclear copper(I1) units of axial sym- 
metry (Table 1) and is comparable tothose of the spin- 
triplet states of magnetically coupled dicopper(II,II) 
complexes [25,27]. Based on these ESR spectral 
properties along with other spectral data, dinuclear 
structure are proposed for these complexes of the type 
[Cu(Ibup)2(diimine)]2 (diimine = bpy or phen) in the 
solid state and the dinuclearity of these complexes i , 
at least partially, preserved in methanolic solutions 
with the monomeric units being bridged by two ibu- 
profenato ligands. In addition, spectral parameters 
for complexes 1 and 2 are comparable to those of 
previously reported for other dinuclear copper(II) 
carboxylates with diimines [26,28], such as [Cu(4- 
aminobenzoate)2(H20) (phen)]2 (NO3)2 [26] and 
[Cu(acetate)2(OC103)(bpy)]2 [28]. X-ray analysis of 
these complexes howed that the geometry at each 
copper(II) atom is distorted square-pyramidal. The 
basal coordination sites are occupied by the nitrogen 
atoms of a chelating diimine and two oxygen atoms 
of bridging carboxylates and the apical position is 
occupied by an oxygen atom of a monodentate ligand 
(water or perchlorato group). The dinuclear structure 
is stabilized by diimine~liimine stacking interactions. 
The structure of complex 1 or 2 (Scheme 2) can be 
described in the same manner, except ibuprofenato 
groups replaced both the bridging 4-aminobenzoato 
or acetato groups and the terminal monodentate 
ligands (water or perchlorato group). 
The frozen-solution ESR spectrum of complex 3 
[Fig. 2(b)] is clearly of rhombic type (Table 1), sug- 
gesting adistortion from square symmetry in solution. 
No signals due to a triplet state were observed in the 
spectrum of this compound, which is consistent with 
its mononuclear structure. The lowest 9 value (2.035) 
lies between the values obtainable in rhombic spectra 
for distorted square-based pyramidal or for distorted 
trigonal-bipyramidal geometry [22]. The structure 
deviation from square symmetry is attributed to the 
presence of methyl groups in the 2 and 9 positions on 
the phenanthroline moiety, close to the coordinated 
nitrogens to copper(II). In addition, the absence of 
the ~4N superhyperfine splitting may be attributed to 
the deviation from square symmetry. The ESR and 
other spectral parameters for complex 3 (Scheme 3) 
are comparable to those of ternary mononuclear cop- 
per(II) complexes of 2,5-dimethoxycinnamic acid or 
3,5-disubstituted salicylates and 2,9-dimethyl-l,10- 
phennthroline [11, 23]. The crystal structure of the 
ternary complex of 2,5-dimethoxycinnamic acid have 
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been determined [23]. The copper(ll) ion in this com- 
plex is five-coordinated and complexes by two nitro- 
gen atoms from 2,9-dimethyl-l,10-phenanthroline, 
two carboxylic oxygens of a bidentate cinnamic acid 
and one oxygen atom of a monodentate carboxyl 
group of a second cinnamic acid molecule. The 
geometry of the complex has been described as a very 
distorted square pyramid or trigonal bipyramid. 
Inspection of the ESR parameters (Table I) shows 
that A values for complexes I and 2 are greater than 
A,I for complex 3, while g~l values in the former com- 
plexes are smaller. These results are consistent with 
the presence of a stronger equatorial ligand-field in 
complexes 1 and 2 with an in-plane CuN202 chro- 
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mophore, compared with complex 3 with a very dis- 
torted an in-plane CuN202 chromophore. 
The magnetic moments and electronic and IR spec- 
tral data are summarized inTable 2. Complexes 1 and 
2 exhibit magnetic moments values at room tem- 
perature a little lower than normally found in mag- 
netically dilute copper(II) ion complexes, as found in 
complex 3. This is attributed to the presence of weak 
antiferromagnetic coupling in complexes 1 and 2, 
which are proposed to have dinuclear structure as 
shown from spectral data. Facilities to carry out 
detailed magnetic properties with temperature vari- 
ation were not available to us. However, it is worth 
noting that dinuclear copper(II) complexes with dou- 
bly bridged carboxylate groups, including those of 
2,2'-bipyridine as a secondary ligand, are known to be 
weakly antiferromagnetically coupled [26-30]. Their 
-2 J  values are much less than those found in the 
familiar tetracarboxylato-ligand complexes of the 
type Cu2(O2CR)4L2. This decrease has been attributed 
[30] to the decrease in the number of bridging car- 
boxylato groups by which the superexchange inter- 
action is mediated [26-30]. 
The electronic spectra for complexes 1 and 2 
obtained in CH2C12 solutions exhibit one very broad 
absorption band near 675 nm and shoulder near 400 
nm (Table 2). The broad band is assigned to the cop- 
per(II) d-d  transitions. The position of this band fall 
within the range expected for a distorted-tetragonal 
copper(II) environment with an in-plane CuN202 
chromophore [4-7], including those reported for cop- 
per(II) carboxylates with ~,~ -diimine [11, 23, 27, 28]. 
The shoulder near 400 nm is assigned to the charge- 
transfer band, as expected when 7t-g interactions 
between aromatic system are present [36]. 
The electronic spectrum of complex 3 in CH2C12 
solution exhibits a very broad d-d  band at 820 nm, 
similar to that seen for mononuclear copper(II) car- 
boxylates with 2,9-dimethyl- 1,10-phenanthroline [ 11,
23]. The copper(II) ion is five-coordinated, contains 
the CuN202q-O chromophore and complexes by a 
chelating 2,9-dimethyl- 1,10-phanenthroline, one 
bidentate and one monodentate carboxylate groups. 
The low energy of the d-d  electronic transitions i
due to the presence of a pronounced distortion from 
planar symmetry in this complex and it is consistent 
with the ESR spectral data. 
In the solid-state IR spectra, complexes 1 and 2 
possess imilar spectra for the V,s(COO) and v~(COO) 
bands (Table 2), supporting similar structures. Two 
Va~(COO) and two v~(COO) are observed, indicating 
the presence of two types of ibuprofenate groups. 
The bands at 1610 and 1395-1380 cm -l with large 
separation, Av [Vas(COO)--vs(COO)] value of 230-- 
215 cm -~, are assigned to the stretching modes of 
the monodentate carboxyl group. The positions and 
separation between them are comparable to those 
associated with a monodentate coordination of car- 
boxylate group [31]. The bands at 1595 and ca 1420- 
1415 cm - J with Av value of 175-180 cm- ~ are assigned 
to the "bridging" bidentate carboxylate ligand. The 
positions and separation between these frequencies 
are similar to those associated with classical car- 
boxylate bridges (Cu- -O- -C- -O- -Cu) ,  including 
those of Cuz(Ibup)4 [2, 8, 31]. These IR spectral results 
are consistent with the proposed structures of these 
complexes in which two ibuprofenate are bridging two 
copper atoms and one ibuprofenate is coordinated as 
a monodentate ligand to each copper atom. In 
addition to bands of carboxyl groups in complex 1, 
bands due to water molecules were observed at 3530- 
3460 cm J. When this complex was heated at 110°C 
for ca 10-15 min these bands only disappeared from 
the IR spectra, while the rest of the spectrum retained 
its features. This observation indicated that water 
molecules in this complex are not coordinated, but 
are present as lattice molecules which were lost on 
heating. 
Solid-state IR spectra for complex 3 exhibit two 
Vas(COO) and two v~(COO) stretching bands (Table 
2), indicating the presence of two types of ibu- 
profenate ligands. The 1610 and 1380 cm ~ (Av = 230 
cm ~) pair observed in the solid-state are assigned to 
the carboxylate group that acts as a monodentate 
ligand and the 1600 and 1410 cm -~ (Av = 190 cm J) 
pair are assigned to the other carboxylate hat acts as 
Table 2. Magnetic moments and electronic and IR spectral data for copper-ibuprofenate complexes 
/~ar (BM) 
(298 K) /~max (nm) Vasym (CO2) Ysym (CO2) A Y 
Compound Solution Solid (e = dm 3 mol -I cm-I)" (cm -l) (cm z) (cm ~) 
1 1.85 1.80 675(180) 1595 1420 175 
sh. 390(170) b 1610 1395 215 
2 1.84 1.80 680(170) 1595 1415 180 
sh. 400(155) b 1610 1380 230 
3 1.90 1.87 820(120) 1600 1410 190 
1610 1380 230 
4 Diamagnetic 456(6400) 1585 1380 205 
a e is per dimer unit for complex 1and 2. 
b sh. is shoulder. 
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asymmetric bidentate ligand [31]. These results are 
consistent with the proposed mononuclear structure 
containing CuN202 + O chromophore, asdiscussed in 
the above spectral properties. 
In conclusion, all physical measurements carried 
out in this study suggest that complexes 1 and 2 have 
essentially identical dinuclear structures of the type 
[Cu(Ibup)2(diimine)]2, in which a dinuclear structure 
results from the bridging of two ibuprofenate mol- 
ecules by bidentate carboxylic groups (Scheme 2). In 
these adducts intermolecular stacking which is usually 
connected with g-Tr interactions between the diimine 
ligands (bpy or phen) may be important in deter- 
mining the dinuclear structure. The steric hindrance 
caused by the presence of methyl groups in the 2 and 
9 positions on the diimine (dmph) aromatic rings close 
to the coordination sites, which resulted in a pro- 
nounced distortion in the sphere of coordination, 
complex 3, precludes the possibility of obtaining an 
intermolecular stack between diimine ligands and then 
obtaining the dinuclear structure ; instead only mono- 
nuclear complex of the type Cu(Ibup)2(dmph) was 
obtained (Scheme 3). 
Complex 4, bis(2,9-dimethyl-l,10-phenanthroline) 
copper(I) ibuprofenate, which was obtained by the 
reduction of complex 3 was identified by UV-vis, 
IR and NMR spectral data, in addition to its elemen- 
tal analyses. Its electronic spectrum obtained in 
CH2C12 solution exhibited the metal-to-ligand charge- 
transfer (MLCT) at 456 nm (e = 6400 M- '  cm '). 
The position of this band and its molar absorptivity 
are comparable with those previously reported for the 
Cu(dmph)2 ~ cation [20, 32]. Examination of the 'H 
NMR spectrum, especially the methyl groups of the 
ligand (dmph), showed an upfield change in the chemi- 
cal shift of the six proton at ca 2.4 ppm compared 
with those of the free ligand at ca 2,8 ppm. This shift 
was ascribed to an aromatic ring current effect [32] 
exhibited by cations of the type [(2,9-dialkyl-l,10- 
phenanthroline)2Cu] +. The structure of these cations 
are known to have the distorted tetrahedral geometry 
about the copper atom [20,32]. The other protons of 
dmph ligand were not resolved, but relatively broad 
signals were observed between 7 and 9 ppm. An IR 
spectrum of the complex revealed peaks of coor- 
dinated dmph ligands at 1635, 1505, 1362, 855, 730 
and 550 cm ' and peaks of the carboxyl group of 
ibuprofenate ion at 1585 and 1380 cm ~. The positions 
of these peaks are comparable with those recently 
reported for CuCl(dmph)2 [32a] and (dmph)2 Cu(bu- 
tyrate) [32b]. Collectively, these spectral data suggest 
that complex 4 has structure of the type [(dmph)2Cu] 
(Ibup) (Scheme 4). 
f copper-ibuprofenate complexes 
-r r- jN 
RCOO = ibuprofenat¢ anion 
Scheme 4. 
} 
Hydrolysis of BNPP 
Since the hydrolysed product p-nitrophenolate 
anion shows a characteristic band at 400 nm 
(~: = 14 000 M- ~ cm ~, at pH 7.4) [17a], the hydrolysis 
739 
(Rcoo) 
ofBNPP [bis(p-nitrophenyl)phosphate] by copper(II) 
complexes 1 and 2 can be easily followed spec- 
trophotometrically. The change in absorbance at400 
nm versus time of the reaction with complexes 1 and 
2 was obtained and the pseudo-first-order rate 
constants, kobs, for the two complexes were found to be 
1.0× 10 5 s-~ and 0.7x 10 5 s ~. ~ respectively. These 
values showed rate enhancement of ca 3.6 x 103 and 
2.6 x 103 in the presence of 1 mM of complex 1 or 2, 
respectively, compared with the rate constant of the 
uncatalysed reaction (kunc) of ca 2.75 x 10 9 s ~ at 
70°C and pH 7.4 [17d]. It was not possible to obtain 
kinetic data for complex 3 due to its reduction to 
copper(I) diimine adduct at 70'C in aqueous meth- 
anol solution. This was judged by the disappearance 
of the copper(II) d-d transition band at 820 nm and 
the appearance of an intense metal-to-ligand charge- 
transfer band at 456 nm characteristic of the copper(I) 
diimine adduct, 4. 
BNPP has been used as a model for hydrolytic 
cleavage of the phosphodiester backbone of DNA and 
RNA [18a,b]. Several possible mechanisms for the 
hydrolysis of phosphate diesters, including BNPP, by 
transition-metal complexes have been proposed [17, 
18]. In these mechanisms the metal ions supply elec- 
trophilic acceptor sites for the phosphodiester's 
P--O followed by an external nucleophilic (H20 or 
OH-) attack or an intramolecular metal hydroxide 
attack at P--O, which then facilitates the hydrolysis 
ofp-nitrophenolate groups. In addition, cooperation 
between metal ions and carboxyl groups of the ibu- 
profenate ions which may make a nucleophilic attack 
at phosphodiester cannot be ruled out in the hydroly- 
sis of BNPP in the presence of complex 1or 2. Detailed 
kinetic studies and the potential application of these 
new complexes in the hydrolysis of biological phos- 
phoric ester is being investigated. 
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